Cargando…
Anti-inflammatories in Alzheimer’s disease—potential therapy or spurious correlate?
Epidemiological evidence suggests non-steroidal anti-inflammatory drugs reduce the risk of Alzheimer’s disease. However, clinical trials have found no evidence of non-steroidal anti-inflammatory drug efficacy. This incongruence may be due to the wrong non-steroidal anti-inflammatory drugs being test...
Autores principales: | Rivers-Auty, Jack, Mather, Alison E, Peters, Ruth, Lawrence, Catherine B, Brough, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585697/ https://www.ncbi.nlm.nih.gov/pubmed/33134914 http://dx.doi.org/10.1093/braincomms/fcaa109 |
Ejemplares similares
-
Zinc Status Alters Alzheimer's Disease Progression through NLRP3-Dependent Inflammation
por: Rivers-Auty, Jack, et al.
Publicado: (2021) -
Mitochondrial Abnormalities and Synaptic Loss Underlie Memory Deficits Seen in Mouse Models of Obesity and Alzheimer’s Disease
por: Martins, Isaura V.A., et al.
Publicado: (2016) -
Salmonella typhimurium-induced IL-1 release from primary human monocytes requires NLRP3 and can occur in the absence of pyroptosis
por: Diamond, Catherine E., et al.
Publicado: (2017) -
Redefining the ancestral origins of the interleukin-1 superfamily
por: Rivers-Auty, Jack, et al.
Publicado: (2018) -
Nanoparticle-Enabled
Enrichment of Longitudinal Blood
Proteomic Fingerprints in Alzheimer’s Disease
por: Hadjidemetriou, Marilena, et al.
Publicado: (2021)